Gardasil on Trial: Did Merck Mislead the Public on Cervical Cancer Prevention?
Top expert delivers a damning report accusing Merck of misleading the public about Gardasil’s ability to prevent cervical cancer.
With the landmark trial against Merck adjourned until September 2025, new evidence suggests the vaccine manufacturer may have deliberately misrepresented the necessity of mass HPV vaccination.
This revelation comes from an expert report by Dr Sin Hang Lee, a pathologist renowned for his expertise in molecular diagnostics. His findings raise serious concerns about Gardasil’s efficacy and the motives behind its aggressive marketing.
Does Gardasil Prevent Cervical Cancer?
Since its introduction in 2006, Gardasil has been marketed as a breakthrough in the fight against cervical cancer.
Yet, as Dr Lee bluntly states in his report, “There is no conclusive evidence that Gardasil has prevented a single case of cervical cancer in the past 18 years.”